Profile: Fisher & Paykel Healthcare, Inc.

Return

Fisher & Paykel Healthcare, a world leader in heated humidification systems, introduces Optiflow™ for Nasal High Flow Therapy. In your Emergency Department, Optiflow™ delivers humidified gas, with or without supplemental oxygen, at flows up to 60 L/min for the treatment of your respiratory compromise patients. Clinical evidence proves that early implementation of Nasal High Flow Therapy can reduce escalation and risk of intubation. Reducing therapy escalation to mechanical ventilation (intubation/NIV) can provide fewer ICU admissions, improved bed flow and reduced ED boarders.

  • Clemmis Futrell
    Clinical Affairs Specialist
  • Emma Hefford
    Senior Marketing Manager
  • Steve Lacke
    Vice President of Sales and Marketing
[ Feedback → ]